Johan Hansson

16.4k total citations
107 papers, 5.4k citations indexed

About

Johan Hansson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Johan Hansson has authored 107 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 46 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Johan Hansson's work include Cutaneous Melanoma Detection and Management (35 papers), Melanoma and MAPK Pathways (27 papers) and Cancer Genomics and Diagnostics (15 papers). Johan Hansson is often cited by papers focused on Cutaneous Melanoma Detection and Management (35 papers), Melanoma and MAPK Pathways (27 papers) and Cancer Genomics and Diagnostics (15 papers). Johan Hansson collaborates with scholars based in Sweden, United Kingdom and United States. Johan Hansson's co-authors include Ulrik Ringborg, Anton Platz, Katarina Omholt, Maria C. Shoshan, Aleksandra Mandic, Suzanne Egyházi, Stig Linder, Joakim Lundeberg, Mats Brommels and Lena Kanter and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Johan Hansson

105 papers receiving 5.3k citations

Peers

Countries citing papers authored by Johan Hansson

Since Specialization

Citations

This map shows the geographic impact of Johan Hansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Hansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Hansson more than expected).

Fields of papers citing papers by Johan Hansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Hansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Hansson. The network helps show where Johan Hansson may publish in the future.

Co-authorship network of co-authors of Johan Hansson

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Hansson. A scholar is included among the top collaborators of Johan Hansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Hansson. Johan Hansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma 2017 ·BMC Cancer ·(unknown), Hemming Johansson, Rainer Tuominen, Marianne Frostvik Stolt, Johan Hansson, Søren Brage	7
2	Simple and cost-effective liquid chromatography-mass spectrometry method to measure dabrafenib quantitatively and six metabolites semi-quantitatively in human plasma 2017 ·Analytical and Bioanalytical Chemistry ·Svante Vikingsson, (unknown), Johan Hansson, Veronica Höiom, Henrik Gréen	11
3	Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial 2015 ·The Lancet Oncology ·Nicole Basset‐Séguin, Axel Hauschild, Jean‐Jacques Grob, Rainer Kunstfeld, Brigitte Dréno, Laurent Mortier, (unknown), Lisa Licitra, Caroline Dutriaux, L. Thomas, Thomas Jouary, Nicolás Meyer, B. Guillot, Reinhard Dummer, Kate Fife, D. Scott Ernst, Sarah Williams, A. Fittipaldo, Ioannis Xynos, Johan Hansson	170
4	Implementation of evidence-based rehabilitation for non-specific back pain and common mental health problems: a process evaluation of a nationwide initiative 2015 ·BMC Health Services Research ·Elisabeth Björk Brämberg, (unknown), Irene Jensen, Hillevi Busch, Gunnar Bergström, Mats Brommels, Johan Hansson	17
5	MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma 2014 ·International Journal of Cancer ·Rainer Tuominen, Rosalyn Jewell, Joost J. van den Oord, Pascal Wolter, Ulrika Stierner, Christer Lindholm, Carolina Johansson, (unknown), Hemming Johansson, Marianne Frostvik Stolt, Christy Walker, Helen Snowden, Julia Newton‐Bishop, Johan Hansson, Suzanne Egyházi Brage	40
6	Strategies to facilitate implementation and sustainability of large system transformations: a case study of a national program for improving quality of care for elderly people 2014 ·PubMed Central ·Monica Nyström, (unknown), Johan Hansson, Henna Hasson	29
7	Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines 2013 ·Melanoma Research ·Carolina Johansson, Alireza Azimi, Marianne Frostvik Stolt, Seyedmehdi Shojaee, (unknown), (unknown), Johan Hansson, Suzanne Egyházi Brage	22
8	What Happened to the No-Wait Hospital? A Case Study of Implementation of Operational Plans for Reduced Waits 2012 ·Quality Management in Health Care ·Johan Hansson, (unknown), John Øvretveit, Jan Carlsson, Mats Brommels	9
9	Context challenges the champion: improving hip fracture care in a Swedish university hospital 2012 ·International Journal of Health Care Quality Assurance ·(unknown), Johan Hansson, John Øvretveit, Mats Brommels	10
10	Genome‐wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma 2011 ·Genes Chromosomes and Cancer ·Veronica Höiom, Rainer Tuominen, Johan Hansson	7
11	Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers 2010 ·BMC Psychiatry ·(unknown), Johan Hansson, Mats Brommels, Anna Åberg Wistedt, Yvonne Forsell	120
12	Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas 2008 ·Molecular Cancer Therapeutics ·Keiran S.M. Smalley, Mercedes Lioni, Maurizia Dalla Palma, Min Xiao, Brijal Desai, Suzanne Egyházi, Johan Hansson, (unknown), Alastair J. King, Patricia Van Belle, David E. Elder, Keith T. Flaherty, Meenhard Herlyn, Katherine L. Nathanson	244
13	Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma 2008 ·Cancer Immunology Immunotherapy ·C. Christian Johansson, Suzanne Egyházi, Giuseppe Masucci, Helena Harlin, Dimitrios Mougiakakos, Isabel Poschke, Bo Nilsson, (unknown), Rainer Tuominen, (unknown), Marianne Frostvik Stolt, Johan Hansson, Rolf Kiessling	41
14	Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro 2008 ·International Journal of Cancer ·Malihe Eskandarpour, Fei Huang, Karen A. Reeves, Edwin Clark, Johan Hansson	47
15	Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site 2007 ·Molecular Oncology ·Anton Platz, Suzanne Egyházi, Ulrik Ringborg, Johan Hansson	201
16	NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing 2006 ·Melanoma Research ·Esther Edlundh-Rose, (unknown), Katarina Omholt, Eva Månsson‐Brahme, Anton Platz, Johan Hansson, Joakim Lundeberg	251
17	Skin Cancer Identification Using Multifrequency Electrical Impedance—A Potential Screening Tool 2004 ·IEEE Transactions on Biomedical Engineering ·Peter Åberg, Ingrid Nicander, Johan Hansson, Paul Geladi, (unknown), Stig Ollmar	217
18	Genetic testing for melanoma 2002 ·The Lancet Oncology ·Richard Kefford, Julia Newton‐Bishop, Margaret A. Tucker, Brigitte Bressac–de Paillerets, Giovanna Bianchi‐Scarrà, Wilma Bergman, Alisa M. Goldstein, Susana Puig, Rona M. MacKie, David E. Elder, Johan Hansson, Nicholas K. Hayward, David Hogg, Håkan Olsson	72
19	Cytoplasmic and nuclear accumulation of ?-catenin is rarely caused byCTNNB1 exon 3 mutations in cutaneous malignant melanoma 2001 ·International Journal of Cancer ·Katarina Omholt, Anton Platz, Ulrik Ringborg, Johan Hansson	79
20	Difference in cis diamminedichloroplatinum cddp toxicity between two human melanoma cell lines is correlated to different levels of dna crosslinking 1988 ·Ulrik Ringborg, Johan Hansson, Víctor M. Castro, M Edgren, Bengt Mannervik	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact